C83.80
Other non-follicular lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Other non-follicular lymphoma, unspecified site, is a type of blood cancer that originates in the lymphatic system. Lymphomas are cancers that develop from lymphocytes, a type of white blood cell essential for the immune system. This specific classification, coded as C83.80 in the ICD-10 system, refers to cases where the exact location of the lymphoma is not specified, but the disease is identified as a non-follicular type, which differs from follicular lymphomas in its cellular characteristics. Understanding this condition helps in grasping the basics of lymphoma diagnosis and treatment options, although specifics vary based on individual situations.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocyte cells. Exposure to certain environmental toxins or chemicals. History of infections that may influence immune function. Weakened immune system due to other illnesses or medical treatments. Age-related changes in immune cell function. Family history of lymphomas or other hematologic cancers.
Key Symptoms: Swelling or painless lumps in lymph nodes, often in the neck, armpits, or groin. Unexplained weight loss. Persistent fatigue or weakness. Fever or night sweats without an apparent infection. Itching skin. Unexplained pain or discomfort due to enlarged lymph nodes. Reduced appetite or feeling full after small meals.
Diagnostic & Treatment
Diagnosis Path: Blood tests to assess overall health and detect abnormal cells. Imaging studies, such as CT or PET scans, to locate lymph node abnormalities. Lymph node biopsy to examine tissue cells microscopically and determine the subtype of lymphoma. Bone marrow biopsy to evaluate whether the disease has spread to the marrow. Additional molecular and genetic testing might be performed for detailed disease characterization.
Treatment Protocols: Chemotherapy to destroy cancerous cells. Immunotherapy, which uses medications that stimulate the immune system to target lymphoma cells. Targeted therapy drugs designed to interfere with specific molecular pathways in cancer cells. Radiation therapy for localized disease or symptom control. Stem cell or bone marrow transplants in advanced or resistant cases. Supportive care to manage symptoms and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is C83.80 a billable ICD-10 code?
Yes, C83.80 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.80?
Clinical documentation must specify the nature of Other non-follicular lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference